Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

CoolVida Highlights the Growing Demand for Non-Hormonal Menopause Support


News provided by

Res-Q Natural Supplements

May 19, 2026, 13:15 ET

Share this article

Share toX

Share this article

Share toX


CoolVida by Res-Q is responding to the growing demand for non-hormonal menopause support with a clinically researched formula designed to help manage hot flashes, night sweats, sleep disruption, and temperature fluctuations naturally. Featuring patented geniVida® TG genistein, CoolVida offers women a science-backed alternative to hormone-based therapies as more consumers seek gentler, body-supportive menopause solutions.

PENNSBURG, Pa., May 19, 2026 /PRNewswire-PRWeb/ -- The conversation around menopause care is evolving, with more women seeking non-hormonal solutions to support this significant life transition.

CoolVida by Res-Q reflects this shift, offering a targeted approach to help manage common symptoms like hot flashes, night sweats, and temperature fluctuations—without the use of synthetic hormones—helping women regain a sense of balance with a non-hormonal option designed to support comfort and confidence while navigating every stage of menopause.

"We're seeing a clear shift toward solutions that support the body rather than override it." - Michael Swift, Res-Q CEO.

Post this

"Women are becoming more informed and intentional about how they approach menopause, and we're seeing a clear shift toward solutions that support the body rather than override it," said Res-Q CEO Michael Swift. "CoolVida was developed to meet that need—offering a non-hormonal option grounded in science and designed for real, everyday relief."

Despite the fact that hot flashes affect up to 75–80% of women during menopause, many women still go untreated or simply try to push through the symptoms without support, often assuming discomfort is just something they have to accept as part of aging.

Already trusted by customers nationwide, CoolVida is gaining attention as more women are empowering themselves and looking for ways to manage symptoms without turning to hormone-based therapies. At the core of its formula is geniVida® TG, a patented, high-potency form of genistein, a nature-identical isoflavone that supports hormonal balance and helps the body respond more calmly to internal changes, supporting hot flash relief and more restful sleep.

CoolVida works by helping maintain estrogen homeostasis, which plays a key role in stabilizing the body's internal temperature regulation. As estrogen levels decline during menopause, this system can become disrupted, leading to frequent hot flashes. Clinical research has shown that geniVida® TG in CoolVida can help reduce both the frequency and severity of these episodes, offering meaningful, non-hormonal relief. In a double-blind, placebo-controlled clinical trial over 12 weeks, genistein users experienced an average reduction of 2.4 hot flashes per day, along with a significant decrease in the duration of each episode.

Beyond hot flashes, genistein's mild, selective estrogen-like activity supports additional areas affected during menopause, including sleep quality, mood balance, and overall daily comfort. Res-Q's CoolVida formula is 100% non-soy and has been shown to be well-tolerated, with research supporting its safety without adverse effects on breast or uterine tissue.

With approximately 1.3 million women entering menopause each year in the United States, demand continues to grow for effective, gentler alternatives to hormone therapy. CoolVida meets this need by combining clinically studied ingredients with a targeted, body-supportive approach.

For more information, visit www.res-q.com/coolvida.

About Res-Q Natural Supplements:

Founded in 1985, Res-Q is a trusted leader in research-driven nutritional supplements, with a legacy rooted in heart health and omega-3 innovation. Established by nutritional visionary Tim Shields, Res-Q was built on a mission to deliver effective, science-backed solutions that help people live healthier lives. Today, the company offers a range of high-intensity formulas designed to support heart, brain, joint, hormonal, sleep, stress, and overall wellness. Each product is crafted using clinically studied ingredients, effective dosages, and rigorous quality testing to ensure purity and potency. Backed by over 40 years of integrity, expertise, and personalized support, Res-Q remains committed to delivering natural solutions that make a meaningful difference in everyday health and elevating wellness.

Media Contact:
Joshua Herring
E-commerce Marketing Coordinator
[email protected]
610-737-9852

Media Contact
Joshua Herring, Res-Q Natural Supplements, 1 6107379852, [email protected], https://www.res-q.com 

SOURCE Res-Q Natural Supplements

Modal title

Res-Q CoolVida is a breakthrough supplement specifically designed to provide fast, effective relief for women experiencing hot flashes and other menopausal symptoms.
View PDF
Res-Q CoolVida is a breakthrough supplement specifically designed to provide fast, effective relief for women experiencing hot flashes and other menopausal symptoms.
Res-Q CoolVida is a breakthrough supplement specifically designed to provide fast, effective relief for women experiencing hot flashes and other menopausal symptoms.

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.